Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, USA
)
ISSN
(Electronic):
1932-6203
Publication date Collection: 2013
Publication date
(Electronic):
1
April
2013
Volume: 8
Issue: 4
Electronic Location Identifier: e59586
Affiliations
[1
]Neurodegenerative Disorders, Garvan Institute of Medical Research, Neuroscience Department,
Sydney, Australia
[2
]Faculty of Medicine, University of New South Wales, Sydney, Australia
[3
]Research School of Biology, Australian National University, Canberra, Australia
University of New South Wales, Australia
Author notes
Competing Interests: The authors have received funding from two commercial funders; Gleneagle Securities’
and Amadeus Energy Ltd. This does not alter the authors’ adherence to all the PLOS
ONE policies on sharing data and materials.
Conceived and designed the experiments: AW BV AA RZ. Performed the experiments: AW
RZ LK SB RT BH. Analyzed the data: AW RZ BH. Contributed reagents/materials/analysis
tools: BV. Wrote the paper: AW RZ AA IC BV.
[¤a]
Current address: Institute of Molecular Biosciences, University of Graz, Graz, Austria
[¤b]
Current address: School of Biomedical Sciences and Pharmacy, University of Newcastle,
Callaghan, Australia
Article
Publisher ID:
PONE-D-12-35806
DOI: 10.1371/journal.pone.0059586
PMC ID: 3613362
PubMed ID: 23560052
SO-VID: 50bcc0f8-0702-4c27-94e3-19c7ae34eafc
Copyright statement:
Copyright @
2013
License:
This is an open-access article distributed under the terms of the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original author and source are credited.
Funding provided by Iain S. Gray Foundation, Stanley and John Roth, Patricia A. Quick
foundation, David King, Doug Battersby, Tony and Vivian Howland-Rose, Walter and Edith
Sheldon, Gleneagle Securities, Bill Gruy, Geoffrey Towner, Amadeus Energy Ltd., Nick
and Melanie Kell, J. O. and J. R. Wicking Trust and the Mason Foundation, the New
South Wales Government, through their office for Science and Medical Research, and
SpinalCure Australia. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Subject:
Research Article
Subject:
Biology
Subject:
Immunology
Subject:
Immunologic Subspecialties
Subject:
Neuroimmunology
Subject:
Neuroscience
Subject:
Animal Cognition
Subject:
Cognitive Neuroscience
Subject:
Learning and Memory
Subject:
Neuroanatomy
Subject:
Neurobiology of Disease and Regeneration
Subject:
Medicine
Subject:
Clinical Immunology
Subject:
Immunologic Subspecialties
Subject:
Neuroimmunology
Subject:
Neurology
Subject:
Dementia
Subject:
Alzheimer Disease